Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Elevated LDL-Cholesterol (LDL-C)”

100 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 100 results

Not applicableStudy completedNCT01690312
What this trial is testing

Clinical Study to Assess High-DHA Fish Oil on Biomarkers of Cardiovascular Disease Risk in Adults on Statin Therapy

Who this might be right for
Cardiovascular Disease
Nutrasource Pharmaceutical and Nutraceutical Services, Inc. 36
Large-scale testing (Phase 3)Study completedNCT06005597
What this trial is testing

Study of Obicetrapib & Ezetimibe Fixed Dose Combination on Top of Maximum Tolerated Lipid-Modifying Therapies

Who this might be right for
DyslipidemiasHypercholesterolemiaFamilial Hypercholesterolemia+2 more
NewAmsterdam Pharma 407
Large-scale testing (Phase 3)Study completedNCT01516879
What this trial is testing

Durable Effect of PCSK9 Antibody CompARed wiTh placEbo Study

Who this might be right for
Hypercholesterolemia
Amgen 905
Large-scale testing (Phase 3)Study completedNCT04807400
What this trial is testing

Study in Primary Care Evaluating Inclisiran Delivery Implementation + Enhanced Support

Who this might be right for
Atherosclerotic Cardiovascular DiseaseAtherosclerotic Cardiovascular Disease Risk EquivelentsElevated Low Density Lipoprotein Cholesterol
Novartis Pharmaceuticals 892
Large-scale testing (Phase 3)Study completedNCT01763827
What this trial is testing

Monoclonal Antibody Against PCSK9 to Reduce Elevated LDL-C in Subjects Currently Not Receiving Drug Therapy for Easing Lipid Levels-2

Who this might be right for
Hyperlipidemia
Amgen 615
Early research (Phase 1)Enrolling By InvitationNCT06504043
What this trial is testing

A Study on Evaluating the Safety of HST101 in Healthy Chinese Participants

Who this might be right for
HypercholesterolemiaHealthy VolunteersLDL-Cholesterol
Hasten Biopharmaceutical Co., Ltd. 30
Early research (Phase 1)Study completedNCT03427710
What this trial is testing

A First In Human Study to Assess CiVi007 in Subjects With an Elevated LDL-Cholesterol Level

Who this might be right for
Hypercholesterolemia
Civi Biopharma, Inc. 36
Early research (Phase 1)Study completedNCT05912296
What this trial is testing

A Single and Multiple Ascending Doses Study to Evaluate the Safety, Tolerability and Pharmacokinetics of RBD7022

Who this might be right for
Hyperlipemia
Suzhou Ribo Life Science Co. Ltd. 80
Testing effectiveness (Phase 2)Study completedNCT01375764
What this trial is testing

Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects

Who this might be right for
Hyperlipidemia
Amgen 160
Early research (Phase 1)Not Yet RecruitingNCT07074236
What this trial is testing

Pharmacokinetics and Pharmacodynamics Study

Who this might be right for
Primary Hypercholesterolemia or Combined Hyperlipidemia Characterized by Elevated LDL-C
Qilu Pharmaceutical Co., Ltd. 48
Not applicableUnknownNCT05218005
What this trial is testing

Advancing Cardiac Care Unit-based Rapid Assessment and Treatment of hypErcholesterolemia

Who this might be right for
Familial HypercholesterolemiaFamilial Hypercholesterolemia Due to Genetic Defect of Apolipoprotein BFamilial Hypercholesterolemia Due to Heterozygous LDL Receptor Mutation+5 more
University of British Columbia 250
Large-scale testing (Phase 3)Active Not RecruitingNCT07000123
What this trial is testing

A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With Clinical ASCVD or at Risk for a First ASCVD Event

Who this might be right for
Cardiovascular Disease
AstraZeneca 3,046
Early research (Phase 1)Study completedNCT04774003
What this trial is testing

Study of Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inclisiran in Chinese Participants With Elevated Serum LDL-C

Who this might be right for
Hyperlipidemia
Novartis Pharmaceuticals 40
Not applicableNot Yet RecruitingNCT05587621
What this trial is testing

Intensive Lipid-lowering in Patients With STEMI and NSTEMI (Germany on Target)

Who this might be right for
ST Elevation Myocardial InfarctionNon-ST Elevation Myocardial InfarctionLDL-cholesterol
Jena University Hospital 300
Not applicableStudy completedNCT02504736
What this trial is testing

Colesevelam, Lipids And Sugars, South Asian Canadian Trial

Who this might be right for
Dyslipidemia
Canadian Collaborative Research Network 90
Large-scale testing (Phase 3)Study completedNCT00479713
What this trial is testing

Assess the Cholesterol Lowering Effect of an Ezetimibe/Simvastatin Combination Tablet Compared to Another Cholesterol Lowering Drug in Patients With High Cholesterol and With High Cardiovascular Risk (0653A-809)(COMPLETED)

Who this might be right for
Hypercholesterolemia
Organon and Co 618
Large-scale testing (Phase 3)Study completedNCT01849497
What this trial is testing

Study to Assess In-home Use of Evolocumab (AMG 145) Using a Prefilled Syringe or a Prefilled Autoinjector/Pen

Who this might be right for
Primary HypercholesterolemiaMixed Dyslipidemia
Amgen 149
Testing effectiveness (Phase 2)Study completedNCT03060577
What this trial is testing

An Extension Trial of Inclisiran in Participants With Cardiovascular Disease and High Cholesterol

Who this might be right for
Atherosclerotic Cardiovascular DiseaseSymptomatic AtherosclerosisType2 Diabetes+1 more
Novartis Pharmaceuticals 382
Large-scale testing (Phase 3)Study completedNCT05888103
What this trial is testing

Efficacy and Safety of Inclisiran as Monotherapy in Chinese Adults With Low or Moderate ASCVD Risk and Elevated Low-density Lipoprotein Cholesterol.

Who this might be right for
Primary Hypercholesterolemia or Mixed Dyslipidemia
Novartis Pharmaceuticals 207
Not applicableStudy completedNCT06782243
What this trial is testing

Comparison of High and Moderate Intensity Statins in Achieving the Target LDL-C Level After Acute Coronary Syndrome

Who this might be right for
Acute Coronary Syndrome
Khyber Medical University Peshawar 190
Load More Results